Plaque psoriasis is the most common ... WebMD retells one man’s story of living with psoriasis, a sometimes-painful skin condition, and how he has to reassure people it’s not contagious.

Medically reviewed by Marisa Garshick, MD Psoriasis is a chronic (long-term) inflammatory condition that causes red, itchy patches on the skin. It can appear anywhere on the body, but when it affects ...

Psoriasis can be painful and interfere with sleep ... A voice-over introduces the silent protagonist, "Introducing, Ned's ...

The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.

Ilumya’s (tildrakizumab-asmn) dosage for moderate to severe plaque psoriasis is typically 100 milligrams. Your dosing schedule may vary based on factors that include your symptoms and other ...

The efficacy and safety of a proposed biosimilar and ustekinumab are similar among adults with moderate to severe plaque psoriasis.

It is approved for use in rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and adults with chronic moderate-to-severe plaque psoriasis. In clinical ...

Even though he suffers from psoriasis, Joel Thomas considers himself a lucky man. Psoriasis is a chronic skin disorder that affects over seven and a half million Americans. Many are not as lucky ...

Plaque psoriasis is an immune-mediated disease estimated ... scaly plaques that may be itchy or painful, which can have a broader impact on a patient's life, including their emotional health ...

Steqeyma, formerly known as CT-P43, is a human interleukin-12 and -23 antagonist indicated for the treatment of: Moderate to severe plaque psoriasis in adult and pediatric patients 6 years of age ...